Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-kappaB activation (Q40275786)

19 September 2017

Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-kappaB activation (English)

1 reference

19 September 2017

0 references

1 reference

Elizabeth A Mann

1

1 reference

PubMed ID

16723161

19 September 2017

Sandra Stanford

series ordinal

2

1 reference

PubMed ID

16723161

19 September 2017

Kenneth E Sherman

series ordinal

3

1 reference

19 September 2017

24 May 2006

1 reference

19 September 2017

1 reference

19 September 2017

121

1 reference

19 September 2017

1

1 reference

19 September 2017

51-57

1 reference

Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation

19 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Nuclear factor-kappa B in the liver of patients with chronic hepatitis C: decreased RelA expression is associated with enhanced fibrosis progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Hepatitis C virus core protein transactivates the inducible nitric oxide synthase promoter via NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Natural history of hepatitis C: its impact on clinical management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Intragraft localization of activated nuclear factor kappaB in recurrent hepatitis C virus disease following liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Nuclear factor-kappa B plays a central role in tumour necrosis factor-mediated liver disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Hepatitis C virus quasispecies and response to interferon therapy in patients with chronic hepatitis C: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Hepatitis C virus core protein and hepatitis activity are associated through transactivation of interleukin-8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Hepatitis C virus core protein suppresses NF-kappaB activation and cyclooxygenase-2 expression by direct interaction with IkappaB kinase beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Additive activation of hepatic NF-kappaB by ethanol and hepatitis B protein X (HBX) or HCV core protein: involvement of TNF-alpha receptor 1-independent and -dependent mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Apoptosis in hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

The Los Alamos hepatitis C sequence database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

The hepatitis C virus non-structural NS5A protein inhibits activating protein-1 function by perturbing ras-ERK pathway signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Hepatitis C virus core protein: intriguing properties and functional relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Distinct functional role of Hepatitis C virus core protein on NF-kappaB regulation is linked to genomic variation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Recent advances in the molecular biology of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

The proteins of the Hepatitis C virus: their features and interactions with intracellular protein phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

AP-1 in cell proliferation and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Cytoplasmic localization is important for transcription factor nuclear factor-kappa B activation by hepatitis C virus core protein through its amino terminal region.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Hepatitis C virus core protein activates nuclear factor kappa B-dependent signaling through tumor necrosis factor receptor-associated factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIRUSRES.2006.04.001

1 reference

19 September 2017

1 reference

PubMed ID

16723161